The genus Streptomyces
belongs to the phylum Actinobacteria
, the members of which are Gram-positive bacteria that are ubiquitous in soils and typically have a genome with a high G+C content. They are known for their capacity for secondary metabolite synthesis and expression of novel enzymes (1
). The strain in this study, Streptomyces
sp. CCM_MD2014, was cocultured with Curtobacterium
sp. strain MR_MD2014 from topsoil around a rusty fire hydrant in Woods Hole, MA (41°31′44.65″N 70°40′21.5″W) on 7 July 2014, using isolation protocols modified from those of El-Nakeeb and Lechevalier (2
). This organism was cultivated as part of the 2014 Microbial Diversity Summer Program at the Marine Biological Laboratory in Woods Hole, MA.
DNA was extracted from the coculture using the Promega Wizard genomic DNA purification kit with 1 h of lysozyme digestion. The DNA was quantified using the Promega QuantiFluor double-stranded DNA (dsDNA) system and then size selected for a minimum length of 4 kb. Size-selected DNA was sequenced on a Pacific Biosciences RSII sequencing platform with P5C3 chemistry. The sequenced fragments were assembled using HGAP3 on the SMRT Portal (3
). The final assembled genome consisted of a single linear chromosome that was 8,274,043 bp long, with a 72.13% G+C content and sequencing coverage of 89×.
The genome was annotated using NCBI's Prokaryotic Genome Annotation Pipeline version 2.8 (rev. 449627) (4
). There were 6,948 coding sequences (CDSs), 6 rRNA operons, and 68 tRNA genes. Neither Clustered Regularly Interspaced Short Palindromic Repeats (CRISPRs) nor prophages were detected in the genome by CRISPRFinder (6
) and PHAST (7
), respectively. The antiSMASH pipeline (8
) predicted 52 secondary metabolite biosynthetic genetic clusters in the genome, including genes for lantipeptides, terpenes, siderophores, polyketide synthases type I and II, bacteriocins, and nonribosomal peptide synthase genes. REBASE (9
) identified 13 candidate methylase genes, and the following methylated motifs were found using Pacific Biosciences SMRT Portal analysis: Am6
AC, and GCCGGC (see organism number 13448 on REBASE website for more details). A multilocus phylogenetic analysis using rpoB
, and atpD
and average nucleotide identity (ANI) (10
) of 93.8% indicated that Streptomyces coelicoflavus
ZGO656 is the closest sequenced genome. A concatenated alignment of these genes was used for phylogenetic reconstruction.
Nucleotide sequence accession number.
The complete genome sequence of Streptomyces sp. strain CCM_MD2014 is available through GenBank under the accession number CP009754.
The isolation and culturing of this organism were carried out as part of the 2014 Microbial Diversity Summer Program at the Marine Biological Laboratory in Woods Hole, MA. The program was supported by generous grants from the Simons Foundation (grant 309981 to the Marine Biological Laboratory), the Beckman Foundation, and the Howard Hughes Medical Institute. This material is based upon work supported by the National Aeronautics and Space Administration (grant NNA13AA92A), the National Science Foundation (grant MCB-1417876), and the U.S. Department of Energy (grant DE-FG02-85ER13361). R.M.M. was supported by a fellowship from Alabama EPSCoR GRSP, Auburn University's Cell and Molecular Biosciences (CMB) Summer Fellowship, Selman A. Waksman Endowed Scholarship in Microbial Diversity, Bernard Davis Endowed Scholarship (no. 47802012050), an Auburn Graduate School Travel Award, and the Joseph Kirby Farrington Endowed Fund for Excellence. These funders had no role in the study design, data collection and interpretation, or the decision to submit the work for publication.
Promega Corporation donated the molecular reagents used in this project. The sequencing for this organism was supported and carried out by Pacific Biosciences. We thank George O’Toole, Alison Butler, Emil Ruff, Arpita Bose, Suzanne Kern, Louis Kerr, Kurt Dahlstrom, Alice Michel, and Cristian Salgado for their assistance and advice.
R.J.R. works for New England BioLabs, a company that sells research reagents, including restriction enzymes and DNA methylases, to the scientific community. J.K. and M.B. are full-time employees at Pacific Biosciences, a company that develops single-molecule real-time sequencing technologies, including the sequencing platform used in this project.
This report was prepared as an account of work sponsored by an agency of the U.S. Government. Neither the U.S. Government nor any agency thereof, nor any of their employees, makes any warranty, expressed or implied, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights. Any reference herein to any specific commercial product, process, or service by trade name, trademark, manufacturer, or otherwise does not necessarily constitute or imply its endorsement, recommendation, or favoring by the U.S. Government or any agency thereof. The views and opinions of authors expressed herein do not necessarily state or reflect those of the U.S. Government or any agency thereof.